Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use
NCT00203450Phase 4Completed
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- May 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in obesity comparing Zonegran with Placebo (2 arms). Primary endpoint: Change in Body Weight at 16 weeks. Started May 2003; status: completed.
02
Drugs
zonisamide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00203450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203450.